Surface Logo New Version-color.png
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617
March 17, 2020 08:00 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Min logo.png
Mass Innovation Nights Partners with Jobcase for Social Impact Showcase
February 06, 2020 15:18 ET | Mass Innovation Nights
CAMBRIDGE, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Mass Innovation Nights (MIN), Massachusetts’ leading new product showcase, is partnering with Jobcase to hold a social impact themed event...
Surface Logo New Version-color.png
Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials
January 27, 2020 16:05 ET | Surface Oncology, Inc.
Company focuses efforts and resources on advancing SRF617 and SRF388; Implements strategic restructuring Initial clinical updates for SRF617 and SRF388 expected by the end of 2020 Extends current...
Min logo.png
Mass Innovation Nights Partners with Verizon 5G Labs for Emerging Healthcare Technology Product Showcase
December 06, 2019 15:35 ET | Mass Innovation Nights
CAMBRIDGE, Mass., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Mass Innovation Nights (MIN), the Boston-region’s leading new product showcase, is partnering with Verizon 5G Labs to hold an emerging healthcare...
Surface Logo New Version-color.png
Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference
November 26, 2019 08:00 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
November 25, 2019 08:00 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
November 18, 2019 06:30 ET | Surface Oncology, Inc.
Details clinical plans for phase 1/1b clinical studies of SRF617 and SRF388 in patients with advanced solid tumors Shares preclinical data for new, CD112R targeted antibody candidate, SRF813, and its...
Surface Logo New Version-color.png
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019
November 12, 2019 06:30 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Jobcase Hires New General Counsel, Benjamin Berman, to Fuel Company’s Growing Worker Empowerment Platform
August 21, 2019 08:00 ET | Jobcase
CAMBRIDGE, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Jobcase (www.jobcase.com), the social platform for the future of work, today announced the appointment of Ben Berman as General Counsel. In...
jobcase.jpg
Jobcase Hires New Product Management Leader to Scale the Jobcase Platform
June 18, 2019 09:17 ET | Jobcase
CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Jobcase (www.jobcase.com), the social platform for the future of work, today announced the hire of Jeff Chow as Senior Vice President of Product...